Comparison of Hybrid IMRT Plans for Breast Cancer Utilizing the Variable Ratio of 3DCRT and IMRT Components to Establish an Optimal Plan for Target Coverage with Sparing Lung and Heart

Document Type : Original Paper

Authors

1 1.Department of Physics, Institute of Applied Science and Humanities, GLA University, Mathura-281406 (U.P.), India. 2.Department of Radiotherapy, Chief Medical Physicist, Saroj Gupta Cancer Centre and Research Institute, Kolkata, India.

2 Chief Medical Physicist, Department of Radiotherapy, Apollo Multispeciality Hospitals, Kolkata, India

3 Department of Mathematics, Institute of Applied Science and Humanities, GLA University, Mathura -281406 (U.P.), India

Abstract

Introduction: Intensity Modulated radiation therapy (IMRT) and Volumetric modulated arc therapy VMAT  enhance PTV coverage, compliance, and homogeneity while minimizing heart and ipsilateral (IL) lung exposure. However, they may increase organ at risks (OARs) dosage and require additional MUs, raising cancer recurrence risk. Hybrid treatment planning is ideal for ca-breast treatments without complex treatment planning technique.
Study aims to achieve the optimal ratio of 3DCRT and IMRT treatment plans in the Hybrid IMRT Plan.
Material and Methods: The study involved 15 left-side breast cancer patients selected from our hospital's medical records. Three different planning strategies were created namely 3DCRT, IMRT and Hybrid IMRT plans. Different ratios of 3DCRT and IMRT treatment plans were kept while creating the Hybrid IMRT treatment plans. All treatment plans were made in the treatment Planning system (TPS) Eclipse (Version 16.1, Varian Medical Systems, Palo Alto, CA, USA), with a prescription dose 40.05Gy in 15 fractions.
Results: Hybrid IMRT 80%, 60%, 40%, and 20% had Unique Dosimetric Index (UDI) scores of 0.989 ±0.022, 0.997±0.256, 0.0999±0.026, and 0.9958±0.0291. The hybrid IMRT80% treatment plan had the lowest Total MU of 497.33±45.36, and V20Gy of Ipsilateral lung was 16.93±3.50%, compared to 17.14±3.39%, 17.51±3.14%, and 17.73±3.0% in IMRT60%, IMRT40%, and IMRT20%. Heart mean dose was lowest in IMRT80% (4.13±1.47Gy) and increased insignificantly from 4.426±1.344Gy to 4.51±1.344Gy in 3DCRT and IMRT100%.
Conclusion: The present dosimetry analysis recommends that hybrid IMRT should be 80% 3DCRT open field and 20% IMRT plan to spare lungs and heart and cover the planning target volume.

Keywords

Main Subjects

References

  1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2021 May;71(3):209-49.
  2. Overgaard M, Nielsen HM, Tramm T, Højris I, Grantzau TL, Alsner J, et al. Postmastectomy radiotherapy in high-risk breast cancer patients given adjuvant systemic therapy. A 30-year long-term report from the Danish breast cancer cooperative group DBCG 82bc trial. Radiother Oncol. 2022 May;170:4-13.
  3. Van de Steene J, Soete G, Storme G. Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link. Radiotherapy and Oncology. 2000 Jun 1;55(3):263-72.
  4. Onitilo AA, Engel JM, Stankowski RV, Doi SA. Survival comparisons for breast conserving surgery and mastectomy revisited: community experience and the role of radiation therapy. Clinical medicine & research. 2015 Jun 1;13(2):65-73.
  5. Early Breast Cancer Trialists' Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. The Lancet. 2005 Dec 17;366(9503):2087-106.
  6. Balaji K, Subramanian B, Yadav P, Radha CA, Ramasubramanian V. Radiation therapy for breast cancer: Literature review. Medical Dosimetry. 2016 Sep 1;41(3):253-7.
  7. Marks LB, Bentzen SM, Deasy JO, Bradley JD, Vogelius IS, El Naqa I, et al. Radiation dose–volume effects in the lung. International Journal of Radiation Oncology* Biology* Physics. 2010 Mar 1;76(3):S70-6.
  8. Giri UK, Sarkar B, Jassal K, Munshi A, Ganesh T, Mohanti B, et al. Left-sided breast radiotherapy after conservative surgery: Comparison of techniques between volumetric modulated arc therapy, forward-planning intensity-modulated radiotherapy and conventional technique. Journal of Radiotherapy in Practice. 2017 Mar;16(1):101-8.
  9. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. New England Journal of Medicine. 2013 Mar 14;368(11):987-98.
  10. Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. International Journal of Radiation Oncology* Biology* Physics. 2006 May 1;65(1):1-7.
  11. Mayo CS, Urie MM, Fitzgerald TJ. Hybrid IMRT plans—concurrently treating conventional and IMRT beams for improved breast irradiation and reduced planning time. International Journal of Radiation Oncology* Biology* Physics. 2005 Mar 1;61(3):922-32.
  12. Shiau AC, Hsieh CH, Tien HJ, Yeh HP, Lin CT, Shueng PW, et al. Left‐sided whole breast irradiation with hybrid‐IMRT and helical tomotherapy dosimetric comparison. BioMed research international. 2014;2014(1):741326.
  13. HALDAR S, DIXIT A, SARKAR B. Dosimetric Study of Hybrid Intensity Modulated Radiation Therapy Treatment Plan with Flattened Filter Free Photon Beam for Carcinoma of Breast: Treatment Planning Study. Turkish Journal of Oncology/Türk Onkoloji Dergisi. 2023 Apr 1;38(2).
  14. Haldar S, Saroj DK, Dixit A, Sarkar B, Yadav S. The feasibility of hybrid IMRT treatment planning for left sided chest wall irradiation: a comparative treatment planning study. Iranian Journal of Medical Physics. 2023 Jan 1;20(1):31-41.
  15. Johansen S, Cozzi L, Olsen DR. A planning comparison of dose patterns in organs at risk and predicted risk for radiation induced malignancy in the contralateral breast following radiation therapy of primary breast using conventional, IMRT and volumetric modulated arc treatment techniques. Acta Oncologica. 2009 Jan 1;48(4):495-503.
  16. Lin JF, Yeh DC, Yeh HL, Chang CF, Lin JC. Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy, and intensity-modulated radiation therapy for left-sided early breast cancer. Medical Dosimetry. 2015 Sep 1;40(3):262-7.
  17. Small Jr W, Bosch WR, Harkenrider MM, Strauss JB, Abu-Rustum N, Albuquerque KV, et al. NRG oncology/RTOG consensus guidelines for delineation of clinical target volume for intensity modulated pelvic radiation therapy in postoperative treatment of endometrial and cervical cancer: an update. International Journal of Radiation Oncology* Biology* Physics. 2021 Feb 1;109(2):413-24.
  18. Hodapp N. The ICRU Report 83: prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT). Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft...[et al]. 2012 Jan;188(1):97-9.
  19. Van't Riet A, Mak AC, Moerland MA, Elders LH, Van Der Zee W. A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate. International Journal of Radiation Oncology* Biology* Physics. 1997 Feb 1;37(3):731-6.
  20. Akpati H, Kim C, Kim B, Park T, Meek A. Unified dosimetry index (UDI): a figure of merit for ranking treatment plans. Journal of applied clinical medical physics. 2008 Jun;9(3):99-108.
  21. Virén T, Heikkilä J, Myllyoja K, Koskela K, Lahtinen T, Seppälä J. Tangential volumetric modulated arc therapy technique for left-sided breast cancer radiotherapy. Radiation Oncology. 2015 Dec;10:1-8.
  22. Kry SF, Salehpour M, Followill DS, Stovall M, Kuban DA, White RA, et al. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. International Journal of Radiation Oncology* Biology* Physics. 2005 Jul 15;62(4):1195-203.
  23. Taylor CW, McGale P, Darby SC. Cardiac risks of breast-cancer radiotherapy: a contemporary view. Clin Oncol (R Coll Radiol). 2006 Apr;18(3):236-46.
  24. Chung E, Corbett JR, Moran JM, Griffith KA, Marsh RB, Feng M, et al. Is there a dose-response relationship for heart disease with low-dose radiation therapy?. International Journal of Radiation Oncology* Biology* Physics. 2013 Mar 15;85(4):959-64.
  25. Ishikura S, Nihei K, Ohtsu A, Boku N, Hironaka S, Mera K, et al. Long-term toxicity after definitive chemoradiotherapy for squamous cell carcinoma of the thoracic esophagus. Journal of clinical oncology. 2003 Jul 15;21(14):2697-702.
  26. Clemente S, Cozzolino M, Chiumento C, Fiorentino A, Caivano R, Fusco V. Monitor unit optimization in RapidArc plans for prostate cancer. Journal of Applied Clinical Medical Physics. 2013 May;14(3):52-63.
  27. Abo-Madyan Y, Aziz MH, Aly MM, Schneider F, Sperk E, Clausen S, et al. Second cancer risk after 3D-CRT, IMRT and VMAT for breast cancer. Radiotherapy and Oncology. 2014 Mar 1;110(3):471-6.
  28. Pignol JP, Olivotto I, Rakovitch E, Gardner S, Sixel K, Beckham W, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. Journal of Clinical Oncology. 2008 May 1;26(13):2085-92.
  29. Kinoshita R, Shimizu S, Taguchi H, Katoh N, Fujino M, Onimaru R, et al. Three-dimensional intrafractional motion of breast during tangential breast irradiation monitored with high-sampling frequency using a real-time tumor-tracking radiotherapy system. International Journal of Radiation Oncology* Biology* Physics. 2008 Mar 1;70(3):931-4.
  30. Zhou S, Zhu X, Zhang M, Zheng D, Lei Y, Li S, et al. Estimation of internal organ motion-induced variance in radiation dose in non-gated radiotherapy. Physics in Medicine & Biology. 2016 Nov 2;61(23):8157.

 

 

 

 

 

Iranian Journal of Medical Physics
Volume 21, Issue 3 - Serial Number 3
May and June 2024
Pages 184-193

Files

History

  • Receive Date: 24 March 2023
  • Revise Date: 04 June 2023
  • Accept Date: 10 June 2023

Share

How to cite

Statistics